Inside Precision Medicine February 19, 2025
Jonathan D. Grinstein, PhD

Jonathan D. Grinstein, PhD, the North American Editor of Inside Precision Medicine, hosts a new series called Behind the Breakthroughs that features the people shaping the future of medicine. With each episode, Jonathan gives listeners access to their motivational tales and visions for this emerging, game-changing field.

Progress in cancer diagnostics has been slow. While there has been progress in cancer screening, including new tests like Cologuard for colorectal cancer, improved mammography, and HPV testing for cervical cancer, the only new cancer added to screening since the start of my career is lung cancer. Despite these advancements, only one in six cancers in the United States is detected through screening, underscoring the need for significant improvement. This is why the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Trends
23andMe bankruptcy: With America's DNA put on sale, market panic gets a new twist
DispatchHealth and Medically Home merge, Updates on Marathon Health, 23andMe’s Bankruptcy and more Healthcare news this week
InnovationRx: Fatal Drug Overdoses Are Falling – But Medicaid Cuts Could Halt Progress
Shared your DNA with 23andMe? Experts say it's time to delete it
23andMe’s Bankruptcy: What Happens To Your DNA Data When A Genetic Testing Giant Fails?

Share This Article